SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Sergio Enriquez-Flores
(Facultad de Ciencias, Facultad de Medicina)

Obras con ISBN:1
Documentos en revistas:41
Colaboraciones en Tesis:3
Patentes:0
Obras con ISBN:
1.- Oxidative Stress and Heat Stress in Experimental Amoebic Liver Abscess (2020)
 
Documentos en revistas:
1.- Post-translational modifications of triosephosphate isomerase reveal metabolic vulnerabilities in T-ALL: effect of combining dichloroacetic acid and the PPI rabeprazole (2026)
 
2.- Propionic acidemia in Mexico: Clinical and genotypic spectrum (2026)
 
3.- Selective Anti-Giardial Action of Indirubin: Biochemical and Functional Evidence for Inhibition of Triosephosphate Isomerase and Aldose Reductase in Giardia lamblia (2026)
 
4.- Antitrypanosomatid and antiamitochondriate activity of new cyclohexyl-quinoxaline-7-carboxylate-1,4-di-N-oxide derivatives: An in silico and in vitro approach toward the elucidation of their mechanisms of action (2026)
 
5.- The Mechanisms of Resistance to JAK Inhibitors in Lymphoid Leukemias: A Scoping Review of Evidence from Preclinical Models and Case Reports (2025)
 
6.- Targeting G6PD with Benzimidazole and Thiazole Derivatives Suppresses SIRT 2 and VEGF Expression and Induces Cytotoxicity in Glioma Cells (2025)
 
7.- Nitazoxanide Analogs: Synthesis, In Vitro Giardicidal Activity, and Effects on Giardia lamblia Metabolic Gene Expression (2025)
 
8.- Integrated Approach for Biochemical and Functional Characterization of Six Clinical Variants of Glucose-6-Phosphate Dehydrogenase (2025)
 
9.- Preliminary exploration of the expression of acetylcholinesterase in normal human T lymphocytes and leukemic Jurkat T cells (2024)
 
10.- Imidazole Carbamates as a Promising Alternative for Treating Trichomoniasis: In Vitro Effects on the Growth and Gene Expression of Trichomonas vaginalis (2024)
 
11.- Deciphering the etiology of undiagnosed ocular anomalies along with systemic alterations in pediatric patients through whole exome sequencing (2024)
 
12.- Pancreatic ß-cell apoptosis in type 2 diabetes is related to post-translational modifications of p53 (Review) (2024)
 
13.- Selective Inhibition of Deamidated Triosephosphate Isomerase by Disulfiram, Curcumin, and Sodium Dichloroacetate: Synergistic Therapeutic Strategies for T-Cell Acute Lymphoblastic Leukemia in Jurkat Cells (2024)
 
14.- Methylglyoxal-Induced Modifications in Human Triosephosphate Isomerase: Structural and Functional Repercussions of Specific Mutations (2024)
 
15.- Evaluation of Three Mutations in Codon 385 of Glucose-6-Phosphate Dehydrogenase via Biochemical and In Silico Analysis (2024)
 
16.- Repurposing of rabeprazole as an anti-Trypanosoma cruzi drug that targets cellular triosephosphate isomerase (2023)
 
17.- Whole exome sequencing provided a genetic diagnosis of unexplained ocular anomalies with systemic alterations in Mexican pediatric patients. (2023)
 
18.- Pyridyl Methylsulfinyl Benzimidazole Derivatives as Promising Agents against Giardia lamblia and Trichomonas vaginalis (2022)
 
19.- Improved yield, stability, and cleavage reaction of a novel tobacco etch virus protease mutant (2022)
 
20.- The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation in a Structure-Dependent Fashion via Toll-like Receptors (2022)
 
21.- Giardia lamblia G6PD::6PGL Fused Protein Inhibitors Decrease Trophozoite Viability: A New Alternative against Giardiasis (2022)
 
22.- Multilevel Approach for the Treatment of Giardiasis by Targeting Arginine Deiminase (2021)
 
23.- Glucose-6-Phosphate Dehydrogenase::6-Phosphogluconolactonase from the Parasite Giardia lamblia. A Molecular and Biochemical Perspective of a Fused Enzyme (2021)
 
24.- Identification and In Silico Characterization of Novel Helicobacter pylori Glucose-6-Phosphate Dehydrogenase Inhibitors (2021)
 
25.- Further Evidence That Defects in Main Thyroid Dysgenesis-Related Genes Are an Uncommon Etiology for Primary Congenital Hypothyroidism in Mexican Patients: Report of Rare Variants in FOXE1, NKX2-5 and TSHR (2021)
 
26.- Cloning, purification, and characterization of the 6-phosphogluconate dehydrogenase (6 PGDH) from Giardia lamblia (2021)
 
27.- Delivery mode-associated gut microbiota in the first 3 months of life in a country with high obesity rates A descriptive study (2020)
 
28.- Rabeprazole inhibits several functions ofEntamoeba histolyticarelated with its virulence (2020)
 
29.- Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target (2020)
 
30.- Functional characterization and subcellular distribution of two recombinant cytosolic HSP70 isoforms from Entamoeba histolytica under normal and stress conditions (2020)
 
31.- First comprehensive TSC1/TSC2 mutational analysis in Mexican patients with Tuberous Sclerosis Complex reveals numerous novel pathogenic variants (2020)
 
32.- On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug (2019)
 
33.- Mechanisms of natural resistance of Balb/c mice to experimental liver amoebiasis (2019)
 
34.- Characterization of proteolytic activities of Giardia lamblia with the ability to cleave His-tagged N-terminal sequences (2019)
 
35.- Testing New Peptides From Toxoplasma gondii SAG1, GRA6, and GRA7 for Serotyping: Better Definition Using GRA6 in Mother/Newborns Pairs With Risk of Congenital Transmission in Mexico (2019)
 
36.- Complement is a rat natural resistance factor to amoebic liver infection (2018)
 
37.- First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target (2018)
 
38.- Differential effects on enzyme stability and kinetic parameters of mutants related to human triosephosphate isomerase deficiency (2018)
 
39.- In silico prediction of the pathogenic effect of a novel variant of BCKDHA leading to classical maple syrup urine disease identified using clinical exome sequencing (2018)
 
40.- Mutational spectrum of PTS gene and in silico pathological assessment of a novel variant in Mexico (2018)
 
41.- MDR1 protein (ABC-C1) Over Expression in Giardia Intestinalis Incubated with Albendazole and Nitazoxanide ()
 
Colaboraciones en Tesis:
1.- Caracterización funcional y estructural de la triosafosfato isomerasa desamidada de humano : propuesta de una enzima glucolítica como blanco selectivo para el desarrollo de compuestos con potencial farmacológico contra la leucemia linfoblástica aguda (2024)
 
2.- Mecanismos moleculares de daño en las etapas tardías del absceso hepático amibiano experimental en hámster (2022)
 
3.- Expresión, purificación y caracterización de la enzima recombinante triosa fosfato isomerasa C232A del parásito intracelular Encephalitozoon intestinalis (2017)
 
Patentes:No hay patentes de este autor.